Related Articles
Patients with normal‑range CA19‑9 levels represent a distinct subgroup of pancreatic cancer patients
Differences and correlation of serum CEA, CA19-9 and CA72-4 in gastric cancer
Preoperative CA19‑9 level and dual time point FDG‑PET/CT as strong biological indicators of borderline resectability in pancreatic cancer: A retrospective study
Prognostic value of serum CEA and CA19‑9 levels in pancreatic ductal adenocarcinoma
Clinical significance of chromodomain helicase/ATPase DNA binding protein 1‑like and human mutL homolog 1 gene expression in cholangiocarcinoma